- Home
- KEN vs BHVN Comparison
KEN vs BHVN Comparison
Compare KEN & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEN
- BHVN
- Stock Information
- Founded
- KEN 2014
- BHVN 2013
- Country
- KEN Singapore
- BHVN United States
- Employees
- KEN N/A
- BHVN N/A
- Industry
- KEN Electric Utilities: Central
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- KEN Utilities
- BHVN Health Care
- Exchange
- KEN Nasdaq
- BHVN Nasdaq
- Market Cap
- KEN 2.2B
- BHVN 1.9B
- IPO Year
- KEN N/A
- BHVN 2017
- Fundamental
- Price
- KEN $45.05
- BHVN $14.01
- Analyst Decision
- KEN
- BHVN Strong Buy
- Analyst Count
- KEN 0
- BHVN 14
- Target Price
- KEN N/A
- BHVN $58.85
- AVG Volume (30 Days)
- KEN 22.9K
- BHVN 1.9M
- Earning Date
- KEN 09-08-2025
- BHVN 08-07-2025
- Dividend Yield
- KEN 10.69%
- BHVN N/A
- EPS Growth
- KEN N/A
- BHVN N/A
- EPS
- KEN 11.35
- BHVN N/A
- Revenue
- KEN $760,304,000.00
- BHVN N/A
- Revenue This Year
- KEN N/A
- BHVN $3.00
- Revenue Next Year
- KEN N/A
- BHVN $59.97
- P/E Ratio
- KEN $3.94
- BHVN N/A
- Revenue Growth
- KEN 5.78
- BHVN N/A
- 52 Week Low
- KEN $23.31
- BHVN $13.75
- 52 Week High
- KEN $46.03
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- KEN 77.94
- BHVN 41.34
- Support Level
- KEN $42.20
- BHVN $13.75
- Resistance Level
- KEN $46.03
- BHVN $15.09
- Average True Range (ATR)
- KEN 0.81
- BHVN 0.71
- MACD
- KEN 0.40
- BHVN 0.14
- Stochastic Oscillator
- KEN 88.01
- BHVN 20.56
About KEN Kenon Holdings Ltd.
Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.